TEST PHANTOM MARKET ANALYSIS

Test Phantom MarketSize and Trends

Test Phantom Market – Dynamics

Increasing prevalence of various chronic diseases such as HIV, tuberculosis, and cancer is expected to contribute to significant growth of the test phantom market. For instance, according to the World Health Organization key fact 2018, cancer was the second leading cause of death worldwide and was responsible for 8.8 million deaths in 2015. Moreover, medical imaging is one of the important parts of healthcare industry, as nearly all the diagnostics and treatment are based upon the analysis provided by the imaging techniques.

Increasing use of imaging techniques in the healthcare sector is expected to propel growth of the test phantom market. For instance, according to National Health Services (U.K.) diagnostic imaging dataset statistical release, around 41 million medical imaging tests were reported in England in 2017, 3.49 million imaging tests were recorded in January 2017, with radiograph being performed 1.89 million times, followed by diagnostic ultrasonography (Ultrasound, 0.77 million), computerized axial tomography (CT scan, 0.40 million), and magnetic resonance imaging (MRI, 0.28 million). Furthermore, government funding for enhanced imaging solutions is expected to significantly boost the market growth. For instance, in 2014, the U.K Government funded US$ 27,327,000 to build an Imaging Center for Excellence (ICE) at the University of Glasgow. However, high maintenance cost related with medical test phantoms is expected to hamper the market growth.